NCT07108114View on ClinicalTrials.gov

SLV-324 Treatment of Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

August 31, 2027

Conditions
Metastatic Solid Tumors
Interventions
DRUG

SLV-324 intravenous (IV infusion)

SLV-324 will be administered as an IV infusion

Trial Locations (3)

63110

RECRUITING

Washington University, St Louis

77030

RECRUITING

MD Anderson Cancer Center, Houston

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

All Listed Sponsors
lead

Solve Therapeutics

INDUSTRY